Allurion Technologies, Inc. (ALUR)
(Delayed Data from NYSE)
$2.77 USD
-0.01 (-0.54%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $2.76 -0.01 (-0.18%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
ALUR 2.77 -0.01(-0.54%)
Will ALUR be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ALUR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ALUR
Flora Growth Corp. (FLGC) Reports Q2 Loss, Tops Revenue Estimates
Zynex Inc. (ZYXI) Reports Q2 Loss, Misses Revenue Estimates
ALUR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion Technologies
4 Medical Product Stocks to Watch From a Challenging Industry
Allurion Technologies, Inc. (ALUR) Q1 Earnings Beat Estimates
Other News for ALUR
Allurion Technologies (ALUR) Reports Positive Long-Term Weight Loss Outcomes | ALUR Stock News
Allurion Announces New Publications on Long-Term Weight Loss Results with the Allurion Program ...
Allurion publishes long-term weight loss results with Allurion Program
12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session
12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session